Yoshioka M, Togashi H, Matsumoto M, Morii K, Saito H
First Department of Pharmacology, Hokkaido University School of Medicine, Sapporo, Japan.
Pharmacol Toxicol. 1990 Jul;67(1):84-7. doi: 10.1111/j.1600-0773.1990.tb00788.x.
The pharmacological effects of a novel, selective muscarinic (M1) receptor agonist, AF102B (cis-2-methyl-spiro-(1,3-oxathiolane-5,3')-quinuclidine hydrochloride hemihydrate), on sympathetic nerve activity are described. Intravenous administration of AF102B (1 and 10 mg/kg) produced a dose-dependent increase in cardiac sympathetic nerve activity accompanied by tachycardia in spinal-intact rats. In addition, AF102B (10 mg/kg) caused a marked increase in cardiac sympathetic nerve activity and heart rate in pithed rats. Pirenzepine (50 micrograms/kg) inhibited these sympathoexcitatory effects of AF102B (10 mg/kg) in pithed rats. These findings suggest that AF102B possesses a sympathoexcitatory action which is mediated by M1-receptors.
本文描述了一种新型选择性毒蕈碱(M1)受体激动剂AF102B(顺式-2-甲基-螺-(1,3-氧硫杂环戊烷-5,3')-奎宁环盐酸盐半水合物)对交感神经活动的药理作用。静脉注射AF102B(1和10毫克/千克)可使脊髓完整的大鼠心脏交感神经活动呈剂量依赖性增加,并伴有心动过速。此外,AF102B(10毫克/千克)可使去大脑大鼠的心脏交感神经活动和心率显著增加。哌仑西平(50微克/千克)可抑制AF102B(10毫克/千克)对去大脑大鼠的这些交感兴奋作用。这些发现表明,AF102B具有由M1受体介导的交感兴奋作用。